Dyne Therapeutics Inc (DYN)

14.42 +0.24  +1.69% NASDAQ Oct 19, 11:25 USD

Dyne Therapeutics PS Ratio

View 4,000+ financial data types
View Full Chart

PS Ratio Chart

Export Data
Save Image
Print Image

Historical PS Ratio Data

View and export this data going back to 1962. Start your Free Trial
Export Data Date Range:
Data for this Date Range  

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Benchmarks

Veracyte Inc 18.02
Moderna Inc 19.67
BridgeBio Pharma Inc 101.08

PS Ratio Related Metrics

Price to Book Value 1.634
Price 14.42
Earnings Yield -25.87%
Market Cap 739.44M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.